Introduction {#Sec1}
============

*Emblica officinalis* (*E. officinalis*), syn: *Phyllanthus emblica*, also known as amla belongs to the Euphorbiaceae family. *E. officinalis* has been reported to possess potential antioxidant effect (Liu et al. [@CR23]). The fruits of amla are used in many medicinal preparations of Ayurvedic and Unani systems of medicine (Kirtikar and Basu [@CR19]). It is also used to treat haemorrhage, diarrhoea and dysentery (Charaka [@CR6]). In folk medicine, all parts of the plant, including fruit, seed, leaf, root, bark and flower are used in various Ayurvedic/Unani herbal preparations (Habib-ur-Rehman et al. [@CR14]).

Amla is highly nutritious and could be important dietary source of vitamin C, minerals and amino acids. It also contains phenolic compounds, tannins, phyllembelic acid, phyllemblin, rutin, curcuminoides and emblicol (Zhang et al. [@CR42]; Jeena et al. [@CR17]). Singh and Sharma ([@CR33]) found that amla was effective in gastric syndromes. The therapeutic efficacy of amla in case of dyspepsia was evaluated (Chawla et al. [@CR7]) with promising results in human subjects. Raw *E. officinalis* fruit is also used for making pickle and preservatives (Ahumada et al. [@CR1]; Deokar [@CR9]; Perry and Metzger [@CR30]). The pharmacological studies shown that amla fruit was able to lower the lipid level in the liver of rabbits. It was also used as an antimicrobial (Rani and Khullar [@CR31]), antitumor (Jeena et al*.*[@CR17]), antipyretic and analgesic agent (Perianayagam et al. [@CR29]; Sharma et al. [@CR32]) as well as has shown hypoglycemic activity. It has also been found to possess potential effect on glucose intolerance, cerebral insufficiency, mental disorders, etc (Nadkarni [@CR25]; Anila and Vijayalakshmi [@CR2]).

Carrageenan induced hind paw inflammation is a neutrophil-mediated acute inflammatory response that produces hind paw swelling, erythema and localized hyperthermia (Leung et al. [@CR22]; Tsuji et al. [@CR38]). Inflammation and tissue injury lead to enhanced pain sensitivity (hyperalgesia), which in part is caused by altered plasticity in the spinal cord (Dubner and Ruda [@CR11]; Woolf and Costigan [@CR41]). Free radicals play an important role in the pathogenesis of inflammation (Di Rosa et al. [@CR10]; Koblyakov [@CR20]; Sood et al. [@CR34]).

Moreover, *E. officinalis* has attracted the attention of researchers as it was found to be an interesting source of phenolic compounds, which include phenolic acids and flavonoids (Suresh Kumar et al. [@CR37]). *E. officinalis* leaf extract possesses antiinflammatory action (Asmawi et al. [@CR4]; Ihantola-Vormisto et al. [@CR16]), but fruit extract containing free and bound phenolic constituents has not been explored yet. Therefore, in the present study, we present the role of free and bound phenolic compounds of *E. officinalis* in acute and chronic inflammation in rats.

Materials and methods {#Sec2}
=====================

Animals {#Sec3}
-------

Sprague-Dawley rats (180--250 g) were procured from Panjab University, Chandigarh. The animals were housed under standard conditions of natural 12 h light and dark cycle with free access to food pellets (Hindustan Lever Products, Kolkata, India) and water. The experimental protocol was duly approved by Institutional Animal Ethics Committee (IAEC) and care of the animals was carried out according to the guidelines of "Committee for the Purpose of Control and Supervision of Experiments on Animals" (CPCSEA), Government of India (Reg No. 874/ac/05/CPCSEA).

Chemicals {#Sec4}
---------

Malondialdehyde (MDA), Folin's phenol reagent, 5,5-dithiobis (2-nitro benzoicacid) (DTNB), 1-chloro 2,4-dinitrobenzene (CDNB) and reduced glutathione were purchased from SISCO Research Laboratories Pvt. Ltd. (Mumbai, India). Carrageenan and diclofenac were obtained from Sigma-Aldrich, USA. All other chemicals used in the experiments were of analytical grade.

Plant materials {#Sec5}
---------------

### Isolation of free phenolic compounds {#Sec6}

Free phenolic compounds of *E. officinalis* were isolated according to the method of Subba Rao and Murlikrishna ([@CR35]). *E. officinalis* fruit powder (1 g) was extracted three times using 70% ethanol (350 mL, 2 h each). The combined extracts were filtered, centrifuged at 3,000 g for 15 min and supernatant was concentrated under reduced pressure. The pH was adjusted to 1.5 with hydrochloric acid (4 N). Phenolic acids were separated by ethyl acetate phase separation (450 mL) and the pooled fractions were treated with anhydrous sodium sulfate, filtered and evaporated to dryness. Total phenolic acid content was estimated spectrophotometrically at 760 nm by Folin--Ciocalteu method with gallic acid as the reference standard and expressed as gallic acid equivalent in milligrams per gram of dry weight sample. Total flavonoid content was determined spectrophotometrically at 358 nm by the aluminum chloride method with rutin as a reference standard and expressed as rutin equivalent in microgram per gram of dry weight sample. The presence of tannins was determined spectrophotometrically at 760 nm by the reduction of phosphotungstomolybdic acid method with tannic acid as a reference standard and expressed as tannic acid equivalent in milligram per gram of dry weight sample.

### Isolation of bound phenolic compounds {#Sec7}

*Emblica officinalis* extract as prepared above (2 g) was defatted with petroleum ether and chloroform (1:1, v/v) and free phenolic acids were extracted with 70% ethanol (450 mL). The dried samples were extracted with sodium hydroxide (1 M, 2,100 mL) containing 0.5% sodium borohydride and the clear supernatants were collected by centrifugation (Nordkvist et al. [@CR26]). The combined supernatants (bound phenolics) were acidified with hydrochloric acid (4 N) to pH 1.5. The phenolic acids were extracted and quantified colorimetrically in the same way as free phenolic acids.

### Characterization of free and bound phenolics compounds of *E. officinalis* {#Sec8}

The active phenolic components of *E. officinalis* extract as prepared above were characterized using HPLC technique (model AKAD06532, Cyberlab Corporation, USA) on a reverse phase C18 column (4.6 × 250 mm) using a diode array UV detector (operating at 275 nm). A solvent system consisting water: acetic acid: methanol (isocratic 80:5:15, v/v) was used as mobile phase at a flow rate of 1 mL/min. In addition, a gradient solvent system (solvent A---water: acetic acid, ratio; 90:10, v/v and solvent B---15% methanol; 0--100% gradient; run time---5 min; flow rate: 1.0 mL/min) were used to resolve ascorbic acid, gallic and tannic acid peaks in the sample. Standard phenolic acids such as caffeic, ferulic, gallic, tannic and vanillic acid along with ascorbic acid were used for the identification of phenolic components present in both free and bound phenolic fractions of *E. officinalis*.

### Carrageenan induced paw oedema {#Sec9}

The paw oedema was induced in rats by 0.1 mL of 1 percentage of carrageenan in saline injecting subcutaneously in the subplantar region of left hind paw, 1 h after the administration of test samples (Brich et al. [@CR5]). The test samples FPEO and BPEO were administered at low and high doses (20 and 40 mg/kg, p.o.). Diclofenac (25 mg/kg, p.o.) was used as a reference drug. The paw volumes of rats were measured by plethysmometer, before and after injection of 1% carrageenan at different time intervals (0.5, 1, 2, 4, 8, 16, and 24 h). Changes in paw volume were recorded at the above-mentioned time intervals.

### Experimental design {#Sec10}

Seven groups were employed in the present antiinflammatory study. Each group consists of six rats.

Group Ι (vehicle control group): 1% of carboxy methyl cellulose (1 mL, p.o.) was administered to the rats.

Group ΙI (negative control group): 0.1 mL of 1 percentage of carrageenan in saline was administered subcutaneously to the rats on the day of the experiment.

Group ΙΙΙ (positive control group): diclofenac sodium (12.5 mg/kg, p.o.) was administered before 1 h of the carragennan administration.

Groups ΙV--VΙI (test groups): rats were pretreated with free and bound phenolic compounds of *E. officinalis* (20 and 40 mg/kg, p.o.) for six consecutive days. On the sixth day, carrageenan was administered to the rats, after 1 h from the test compounds administration.

### Cotton pellet induced granuloma tissue formation {#Sec11}

FPEO, BPEO and diclofenac sodium were orally administered for 16 consecutive days in Groups III--VII. On eighth day, the animals (Groups II--VII) were mildly anaesthetised with ether, four sterile cotton pellets (50 mg) were subcutaneously implanted in the dorsal region of the rats and two at the axilla and two at the groin regions. On 16th day, all the rats were killed using anaesthetic ether and the cotton pellets were dissected out without affecting the surrounding granuloma tissues (Winter and Porter [@CR40]). Chronic inflamed tissues (from axilla and groin regions) were excised and stored in 0.9% saline at −20°C for biochemical analysis. The moist pellets were weighed and then dried at 60°C for 48 h and then again reweighed. The percentage reduction in cotton pellet's weight of the test samples was observed and compared with that of respective cotton pellet and diclofenac sodium treated groups. This provides a measure to assess the antiinflammatory effect of the test samples.

### Experimental design {#Sec12}

Seven groups were employed in the present antiinflammatory study. Each group consists of six rats and experimental protocol included 16 days study. Each group of animals was employed with sterile cotton pellets (50 mg each) implantation in the dorsal region of rats at eighth day.

Group Ι (vehicle control group): 1% of carboxy methyl cellulose (1 mL, p.o.) was administered to the rats for 16 consecutive days.

Group ΙΙ (negative control group): four sterile cotton pellets, 50 mg each were implanted in the dorsal region of rats at eighth day.

Group ΙΙΙ (positive control group): reference standard drug and diclofenac sodium (12.5 mg/kg, p.o.) were administered to the rats for 16 consecutive days.

Groups ΙV--VΙI (test groups): rats were pretreated with free and bound phenolic compounds of *E. officinalis* (20 and 40 mg/kg, p.o.) for 16 consecutive days.

### Biochemical analysis {#Sec13}

At the end of the study (i.e. 16th day), samples from granulomatous tissue were evaluated for the inflammatory and oxidative stress markers.

### Estimation of total protein content {#Sec14}

The protein concentration was estimated according to the method of Lowry et al. ([@CR24]). The protein content was determined spectrophotometrically at 750 nm using bovine serum albumin as a standard. Total protein content was expressed as milligram per gram of tissue.

### Estimation of thiobarbituric acid reactive substances {#Sec15}

Thiobarbituric acid reactive substances (TBARS; as an index of lipid peroxidation) were estimated according to the method of Ohkawa et al. ([@CR27]). The absorbance was measured spectrophotometrically at 532 nm. A standard calibration curve was prepared using 1--10 nM of 1, 1, 3, 3-tetra methoxy propane. TBARS value was expressed as nanomoles per gram of protein.

### Estimation of reduced glutathione {#Sec16}

The reduced glutathione (GSH) content in tissue was estimated using method of Ellman ([@CR13]). Absorbance was noted spectrophotometrically at 412 nm. A standard curve was plotted using 5--50 µM of reduced form of glutathione and the results were expressed as micrograms of reduced glutathione per gram of protein.

### Estimation of myeloperoxidase activity {#Sec17}

The myeloperoxidase (MPO) activity was estimated according to the method of Hillegass et al. ([@CR15]). The presence of MPO was measured at 460 nm for 3 min. MPO activity was expressed as unit per gram protein per minute. One unit of MPO activity was defined as that degrading 1 µmol peroxide per min at 25°C.

### Evaluation of changes in vascular permeability {#Sec18}

The amount of Evans blue in tissue samples was quantified according to the method described by Lange et al. ([@CR21]). Animals were injected with 1 mL of Evans blue (2 mg/kg) via the tail vein 30 min before sacrifice using anaesthetic ether. Evans blue was extracted from the tissues with 4 mL of formamide for 24 h at 50°C. The absorbance was measured at 620 nm. A standard calibration curve was prepared using Evans blue (0.1--1 µg) diluted with formamide. Vascular permeability was expressed as amount in microgram of Evans blue per milligram of protein.

### Statistical analysis {#Sec19}

All the results were expressed as mean ± standard error of means (SEM). The data from the carrageenan induced paw oedema was statistically analyzed by two-way analysis of variance followed by Bonferonni's post test using Graph pad prism Version-5.0 software. The data from the cotton pellet induced granuloma tissue formation and biochemical results were statistically analyzed by one-way analysis of variance (ANOVA) followed by Tukey's multiple range tests using Sigmastat Version-2.0 software and the *p* \< 0.05 was considered to be statistically significant.

Results {#Sec20}
=======

Identification of free and bound phenolic compounds of *E. officinalis* {#Sec21}
-----------------------------------------------------------------------

As previously reported, standardized HPLC protocol was not supported by separation of phenolic acids under isocratic elution condition (Duke [@CR12]; Suresh Kumar et al. [@CR37]). Therefore, we have optimized gradient running system; ascorbic acid was separated with a wide range of retention time (i.e., 1.79 min) relative to that of gallic acid and tannic acid, which eluted at 2.36 min. Moreover, tannic acid (319.4 µg/g of extract) and gallic acid (104.6 µg/g of extract) components have not been separated with this condition, but presence of this compounds identified by peak coincidence with the retention time of standard gallic and tannic acid. It was also revealed that there was absence of ascorbic acid in both free and bound phenolic fractions of *E. officinalis* (Fig. [1](#Fig1){ref-type="fig"}).Fig. 1HPLC profile of free and bound phenolic fractions of*E. officinalis*. HPLC peak in *I* (*a*, *b*, *c*) indicates standard ascorbic acid (RT 1.63), tannic acid (RT 2.41) and gallic acid (RT 2.59), respectively. Further, peaks in *II* and *III* indicate the presence of tannic and gallic acid in both, free and bound phenolic fraction of *E. officinalis*, respectively

Effect of *E. officinalis* on carragennan induced paw oedema {#Sec22}
------------------------------------------------------------

The effect of phenolic compounds of *E. officinalis* on carragennan induced paw oedema was measured by the changes in left hind paw volume of the rats as presented in Figs. [2](#Fig2){ref-type="fig"} and [3](#Fig3){ref-type="fig"}. The paw volume was found to increase as compare to vehicle control group in the carrageenan treated group whereas, diclofenac sodium (12.5 mg/kg) pretreated group have shown decrease in the paw volume as compared to carrageenan treated group. Pretreatment with FPEO and BPEO reduced the carrageenan induced inflammation as indicated by decrease in paw volume. However, only high dose (40 mg/kg) of both fractions have shown significant (*p* \< 0.05) antiinflammatory response which was comparable to the diclofenac sodium pretreated group.Fig. 2Effect of FPEO on carrageenan induced paw oedema. Time course of paw oedema was measured by the carrageenan induced increased paw volume in rats. *DCL* Diclofenac sodium, *FPEO* Free phenolic compounds of *E. officinalis*. Data were expressed as mean ± SEM, *n* = 6 rats per group. *a p* \< 0.05 versus vehicle control groups, *bp* \< 0.05 versus carrageenan treated group and *cp* \< 0.05 versus diclofenac sodium control groupFig. 3Effect of BPEO on carrageenan induced paw oedema. Time course of paw oedema was measured by the carrageenan induced increased paw volume in rats. *DCL* Diclofenac sodium, *BPEO* Bound phenolic compounds of *E. officinalis*. Data were expressed as mean ± SEM, *n* = 6 rats per group. *ap* \< 0.05 versus vehicle control groups, *bp* \< 0.05 versus carrageenan treated group and *cp* \< 0.05 versus diclofenac sodium control group

Effect of *E. officinalis* on granulomatous tissue formation {#Sec23}
------------------------------------------------------------

Table [1](#Tab1){ref-type="table"} shows the effect of FPEO and BPEO on granulomatous tissue changes due to cotton pellet induced chronic inflammation. Changes in the cotton pellets weight (wet weight--dry weight) of the test samples were compared with the cotton pellet and diclofenac sodium (12.5 mg/kg) treated groups. Pretreatment (i.e. on days 1--8) of diclofenac and the phenolic fractions of *E. officinalis* did not show any behavioral changes. Both the fractions have shown reduction in granulomatous tissue mass as compared to cotton pellet treated group. However, only high doses (40 mg/kg) of each fraction have shown significant (*p* \< 0.05) reduction which was comparable to that of diclofenac sodium pretreated group.Table 1Effect of*E. officinalis* on wet and dry weight changes in cotton pellet induced chronic inflammation in rat. Effect of free and bound phenolic compounds of *E. officinalis* on percentage inhibition of granulomatous tissue mass formationGroupsDose (mg/kg)Wet weight(g)Dry weight (g)Difference (g)Percentage inhibitionVehicle + cotton--1,011.4 ± 9.34262.1 ± 2.5749.300.00Cotton--1,008.5 ± 8.72254.4 ± 1.9754.100.00DCL + cotton12.5410.7 ± 5.31^a^212.1 ± 4.2^a^198.6^a^73.50FPEO + cotton20741.8 ± 7.91^b^204.5 ± 3.4^b^537.3^b^23.49FPEO + cotton40423.2 ± 6.47^a^198.3 ± 2.6^a^224.9^a^69.99BPEO + cotton20824.6 ± 5.64^b^209.3 ± 2.1^b^615.3^b^17.88BPEO + cotton40489.4 ± 4.83^a^224.2 ± 3.8^a^265.2^a^64.61*DCL* diclofenac sodium, *FPEO* and *BPEO* free and bound phenolic compounds of *E. officinalis*, respectivelyPercentage inhibition was calculated based on the vehicle treated group valuesValues are mean ± SEM (*n* = 6)^a^*p* \< 0.05, as compared to cotton pellet treated group^b^*p* \< 0.05, as compared to diclofenac sodium pretreated group

Effect of *E. officinalis* on tissue biomarker changes {#Sec24}
------------------------------------------------------

Effects of FPEO and BPEO on biomarker changes due to cotton pellet induced chronic inflammation are shown in Table [2](#Tab2){ref-type="table"}. In the cotton pellet treated group; TBARS, MPO and plasma extravasation levels were found to increase whereas, GSH level was found to decrease as compare to normal control group. However, diclofenac sodium, pretreatment of FPEO and BPEO groups ameliorated the above changes but only high doses (40 mg/kg) of both fractions have shown significant (*p* \< 0.05) ameliorative effect on the biomarker changes which were comparable to that of diclofenac sodium treated group.Table 2Effect of *E. officinalis* on tissue biomarker changes in cotton pellet induced chronic inflammation in rat. Effect of free and bound phenolic compounds of *E. officinalis* on tissue biochemical changesGroupDose (mg/kg)TBARS (nmol/g of protein)GSH (µmol/g of protein)MPO (U/g of protein/min)Evans blue (µg/mg of protein)Vehicle + cotton--4.21 ± 0.340.86 ± 0.021.83 ± 0.140.164 ± 0.02Cotton--4.29 ± 0.290.82 ± 0.021.89 ± 0.210.172 ± 0.01DCL + cotton12.52.17 ± 0.12^a^1.31 ± 0.04^a^0.42 ± 0.13^a^0.052 ± 0.03^a^FPEO + cotton203.84 ± 0.26^b^0.92 ± 0.02^b^1.47 ± 0.19^b^0.156 ± 0.01^b^FPEO + cotton402.56 ± 0.47^a^1.24 ± 0.01^a^0.56 ± 0.11^a^0.063 ± 0.02^a^BPEO + cotton204.09 ± 0.24^b^0.88 ± 0.02^b^1.64 ± 0.11^b^0.163 ± 0.05^b^BPEO + cotton402.92 ± 0.41^a^1.19 ± 0.04^a^0.81 ± 0.03^a^0.079 ± 0.03^a^*DCL* diclofenac, *FPEO* and *BPEO* free and bound phenolic compounds of *E. officinalis*, respectively; *TBARS* thiobarbituric acid reactive substances, *GSH* reduced glutathione, *MPO* myeloperoxidaseValues are mean ± SEM (*n* = 6)^a^*p* \< 0.05, as compared to cotton pellet treated control group^b^*p* \< 0.05, as compared to diclofenac sodium pretreated group

Discussion {#Sec25}
==========

In this study, antiinflammatory effects of *E. officinalis* containing free and bound phenolic compounds were evaluated in carrageenan induced acute and cotton pellet induced chronic inflammation in Sprague-Dawley rats. Phenolic fractions of *E. officinalis* significantly reduced paw volume in acute inflammation. Further, in chronic inflammatory condition, free and bound phenolic compounds containing fractions were found to decrease the granulomatous tissue mass, cotton pellet induced granuloma tissue lipid peroxidation, myeloperoxidase activity and plasma extravasation whereas, there was a rise in the tissue reduced glutathione levels. However, significant effect was observed at high doses of both fractions.

Potential acute and chronic antiinflammatory activities were found in the both the fractions at high dose level (FPEO and BPEO). Further, in HPLC analysis, it was revealed that free phenolic contents of *E. officinalis* were three times more than that of bound form. Both phenolic fractions of *E. officinalis* are consisting of gallic and tannic acid. Phenolic fractions are also known to posses various secondary metabolites, such as flavonoids and phenolic acids, etc., that are well known to posses highest antioxidant activity (Arumugam et al. [@CR3]). It may support the effect of FPEO and BPEO on suppression of the granulomatous tissues formation and free-radical scavenging activity resulted in fall in cotton pellet induced granuloma tissue TBARS and MPO activity, plasma extravasation and rise in GSH level due to the presence of pharmacological active moiety, such as flavonoids and other phenolic compounds (Arumugam et al. [@CR3]; Suleyman et al. [@CR36]). Moreover, flavonoids have been reported to inhibit the cyclooxygenase and lipooxygenase pathways of arachidonate metabolism (Pelzer et al. [@CR28]; Zheng et al. [@CR43]).

The inflammatory process was reported to be associated with the generation of reactive oxygen species (ROS) and reactive nitrogen species (RNS) (Jung et al. [@CR18]). Recently, literature reveals that *E. officinalis* found to posses the phenolic compounds, i.e. flavonoids, phenolic acids, etc. (Suresh Kumar et al. [@CR37]). Phenolic compounds (i.e. gallic acid, tannic acid, etc.) are having strong antioxidant action (Cuvrelier et al. [@CR8]; Subba Rao and Murlikrishna [@CR35]). It is also evident that phenolic compounds obtained from natural source may reduce oxidative stress by free-radical scavenging activity (Liu et al. [@CR23]; Vinson et al. [@CR39]). Further, leaf extract of *E. officinalis* is also expressed antiinflammatory action due to the presence of free phenolic constituents (Ihantola-Vormisto et al. [@CR16]). Hence, the results of the present work suggest that the FPEO and BPEO fractions from the fruit of *E. officinalis* can attenuate the acute and chronic inflammatory response via antioxidant action. It may be concluded that these effects are due to the presence of phenolic compounds. However, further studies are needed to isolate the pharmacologically active compounds and their exact molecular mechanism to explore the antiinflammatory activity.
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